Home Based Molecular Testing Market Share, Trends, Size Growth, Opportunity
The at-home molecular testing market size is projected to be worth US$ 10.2 billion in 2023. The market is expected to cross US$ 18.1 billion by 2033 at a CAGR of 5.9% during the forecast period. Increasing number of diabetes patients around the world is the main factor driving market expansion. For instance, monkey pox and other infectious illnesses pose a severe threat to public health and economic development in all nations. Additionally, the need for early detection of various diseases and growing awareness regarding them are fueling market expansion.
The prospective growth of the at-home testing market was influenced by the population’s growing awareness of home care testing.
Other Drivers Propelling the Demand for At-home Molecular Testing Market include:
The increase in the number of diabetes patients is driving the demand for molecular testing . As of 2021, 537 million individuals worldwide or about 10% of all adults aged 20 to 79 were living with diabetes, according to the latest IDF data.
The production of the newest at-home testing tools and kits, as well as increasing understanding of the advantages offered by these services, are promoting market expansion.
The market for at-home testing kits or medical devices with improved healthcare services has grown as a result of an increase in R&D activity in the field of personalized self-assessment kits for the diagnosis of HIV illness.
At-home kits are simple to obtain and are readily available at pharmacies and online retailers. Additionally, these at-home testing tools are accessible over the counter. As a result, the kits’ widespread availability is promoting market expansion.
Challenges for Companies /Manufacturers in the At-home Molecular Testing Market:
The process of confirming an indiviadual’s concerns have undoubtedly been eased by the at-home molecular kits or devices. However, a key challenge for larger adoption remains the uncertainty about the accuracy of the result.
The complex and evolving regulatory landscape is another restraining factor for the at-home molecular testing market. Compliance with the regulations can be time-consuming and costly for companies, limiting their ability to bring new products to market.
Test menu for at home tests are relatively limited compared to traditional laboratory-based tests. Complex or specialized tests may still require a visit to a healthcare facility, limiting the market potential of at-home testing.
Opportunities
Improved methods of sample collection and increasing focus on personalized medicine offers a significant opportunity for at-home molecular testing market.
The large amount of financial investments made in healthcare sector in emerging markets are crucial in modernizing the laboratory infrastructure in developing nations, which promotes the home-based molecular testing market.
Conclusion
We can safely say that home-based molecular testing market will grow in the future as with increasing innovations in healthcare sector more safe and non-invasive technologies are coming up which can easily be availed even in low income settings.
Request Sample Here
Request for Customized Report Here